Clinical Trials Sponsored by Clinical Trial Consultants, CTC

Total 85 results

BioGaia AB
Atlantia Food Clinical Trials; CTC Clinical Trial Consultants AB

Recruiting

Effect of Probiotic Limosilactobacillus Reuteri (L. Reuteri) on Crying Time in Infants With Colic

Colic, Infantile

Ireland, Sweden
UPM Biomedicals
CTC Clinical Trial Consultants AB

Recruiting

An Investigation of Performance and Safety of the Wound Dressing FibDex in Patients With Superficial Dermal Burns

Burns

Sweden
Nanexa AB
CTC Clinical Trial Consultants AB

Completed

To Assess Safety, Tolerability and PK of NEX-20A, a Subcutaneous Prolonged-release Injection to Healthy Subjects

Multiple Myeloma

Sweden
EpiEndo Pharmaceuticals
CTC Clinical Trial Consultants AB

Completed

Clinical Trial to Assess Effect of Verapamil on Systemic Exposure of EP395 and Effect of EP395 on Systemic Exposure of Midazolam and Digoxin

COPD | Chronic Obstructive Pulmonary Disease Exacerbation

Sweden
Curovir AB
CTC Clinical Trial Consultants AB

Completed

First-in-human Clinical Trial Evaluating CUR-N399 in Healthy Volunteers.

Pulmonary Disease, Chronic Obstructive | Enterovirus Infections | Rhinovirus

Sweden
Pharma Holdings AS
CTC Clinical Trial Consultants AB

Recruiting

Study to Evaluate a Single Dose of LTX-109 in Subjects With COVID-19 (Coronavirus Disease 2019) Infection.

COVID-19

Sweden
Pharma Holdings AS
CTC Clinical Trial Consultants AB

Completed

Study to Evaluate the Efficacy, Safety and Tolerability of 3% LTX-109 for Nasal Decolonisation of Staphylococcus Aureus

Nasal Decolonization of Staphylococcus Aureus

Sweden
Empros Pharma AB
CTC Clinical Trial Consultants AB

Completed

A Proof of Concept Trial in Overweight and Obese Patients, Investigating Effect of EMP16-02 on Body Weight (Primary)

Overweight or Obesity

Sweden
Pharma Holdings AS
CTC Clinical Trial Consultants AB

Completed

A Study to Evaluate the Safety and Efficacy of 3% LTX-109 for Nasal Decolonisation of Staphylococcus

Nasal Decolonization of Staphylococcus Aureus

Sweden
AdjuTec Pharma AS
CTC Clinical Trial Consultants AB

Not yet recruiting

A First-in-human Trial to Evaluate Safety, Tolerability, and Pharmacokinetics of APC148 in Healthy Adults

Healthy Subjects

Sweden
Empros Pharma AB
CTC Clinical Trial Consultants AB

Active, not recruiting

Study Exploring the Supportive Effect of Acarbose in Weight Management

Overweight or Obesity

Sweden
Empros Pharma AB
CTC Clinical Trial Consultants AB

Recruiting

A Phase 1 Study to Evaluate EMP22 PD and EMP16 PK Versus Xenical® in Healthy Volunteers

Overweight or Obesity

Sweden
Gesynta Pharma AB
CTC Clinical Trial Consultants AB

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GS-248

Healthy

Sweden
Vicore Pharma AB
CTC Clinical Trial Consultants AB

Completed

Effect of C21 on Forearm Blood Flow

Study Vasodilatory Effects of C21

Sweden
Dr. Korman Laboratories Ltd.
CTC Clinical Trial Consultants AB

Completed

Safety and Performance of DKL Crosslinked Sodium Hyaluronate 23 Dermal Filler for Improvement of NLF Appearance

Aging, Premature

Sweden
Dr. Korman Laboratories Ltd.
CTC Clinical Trial Consultants AB

Completed

Safety and Performance of DKL Crosslinked Sodium Hyaluronate 26 Dermal Filler for Cheek Augmentation

Aging Problems

Sweden
iCoat Medical AB
Region Skane; CTC Clinical Trial Consultants AB

Active, not recruiting

FIH Phase I/IIa Trial Evaluating Safety of TUM012 to Minimize Ischemic Reperfusion Injury in Kidney Transplantation

Ischemia-reperfusion Injury | Kidney Transplant; Complications

Sweden
Spago Nanomedical AB
CTC Clinical Trial Consultants AB; Antaros Medical

Completed

A First-in-human Clinical Evaluation of SN132D in Patients With Breast and Pancreatic Cancer (SPAGOPIX-01)

Breast Cancer | Pancreas Cancer

Sweden
Swedish University of Agricultural Sciences
Uppsala University; CTC Clinical Trial Consultants AB

Completed

Glucose Kinetics After Wheat and Rye Breads

Diabetes Mellitus, Type 2. Physiology of Glucose Kinetics
Gesynta Pharma AB
CTC Clinical Trial Consultants AB; RISE Research Institutes of Sweden AB

Completed

A Study in Healthy Subjects to Evaluate Pharmacokinetics and Food Effect After Dosing of GS-248

Pharmacokinetic

Sweden
Neogap Therapeutics AB
Karolinska University Hospital; CTC Clinical Trial Consultants AB; Region Västmanland and other collaborators

Recruiting

A First-In-Human Trial of pTTL in Advanced Colorectal Cancer

Colorectal Cancer

Sweden
Inhalation Sciences Sweden AB
CTC Clinical Trial Consultants AB; Pharm-Analyt Labor GmbH; PlantVision AB

Completed

Explorative Clinical Investigation to Investigate the Ability of PreciseInhale to Direct Regional Lung Targeting and Reduce the Degree of Throat Deposition and Subsequent Gastrointestinal Absorption in Healthy Volunteers After Inhalation of Test Drug Substances Via the PreciseInhale System

Nebulizers and Vaporizers

Sweden
Neurolixis SAS
Michael J. Fox Foundation for Parkinson's Research; CTC Clinical Trial Consultants... and other collaborators

Completed

Study to Assess the Safety, Tolerability and Preliminary Efficacy of NLX-112 Versus Placebo in L-dopa-induced Dyskinesia

Medication-Induced Dyskinesia

Sweden
Per Hellström
University of Helsinki; CTC Clinical Trial Consultants AB; Biohit Oyj, Helsinki... and other collaborators

Completed

L-cysteine Prevents Stomach Exposure to Carcinogenic Acetaldehyde

Gastritis, Atrophic

Sweden
Durect
CTI Clinical Trial and Consulting Services

Completed

A Phase 2b Study in Subjects With Alcoholic Hepatitis to Evaluate Safety and Efficacy of DUR-928 Treatment (AHFIRM)

Alcoholic Hepatitis

United States, Australia, United Kingdom, France, Belgium, Austria
Durect
CTI Clinical Trial and Consulting Services

Completed

A Research Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of DUR-928 in Patients With Alcoholic Hepatitis (AH)

Alcoholic Hepatitis

United States
Prokidney
CTI Clinical Trial and Consulting Services

Completed

A Study of a Renal Autologous Cell Therapy (REACT) in Patients With Chronic Kidney Disease (CKD) From Congenital Anomalies of the Kidney and Urinary Tract (CAKUT).

Chronic Kidney Disease | Congenital Anomalies of Kidney and Urinary Tract

United States
Prokidney
CTI Clinical Trial and Consulting Services

Completed

A Study of Autologous Renal Autologous Cell Therapy (REACT) in Patients With Diabetic Chronic Kidney Disease

Type 2 Diabetes Mellitus | Chronic Kidney Disease

United States
Prokidney
CTI Clinical Trial and Consulting Services

Terminated

Autologous Neo-Kidney Augment (NKA) in Patients With Type 2 Diabetes and Chronic Kidney Disease (CKD) (RMCL-CL001)

Type 2 Diabetes | Chronic Kidney Disease

United States
PTC Therapeutics
Cystic Fibrosis Foundation; ECFS-Clinical Trial Network (ECFS-CTN)

Completed

Study of Ataluren in Nonsense Mutation Cystic Fibrosis (ACT CF)

Cystic Fibrosis

United States, Spain, United Kingdom, Netherlands, Germany, France, Belgium, Italy, Australia, Argentina, Brazil, Bulgaria, Canada, Greece, Israel, Poland
Prokidney
CTI Clinical Trial and Consulting Services

Completed

A Study of Renal Autologous Cell Therapy (REACT) in Type 2 Diabetics With Chronic Kidney Disease

Type 2 Diabetes Mellitus | Chronic Kidney Disease

United States
Cytomedix
CTI Clinical Trial and Consulting Services

Terminated

The AutoloGel™ Post-Market Surveillance (TAPS) Program (TAPS)

Diabetic Foot Ulcers | Wounds | Pressure Ulcers | Leg Ulcers

United States
Alexion Pharmaceuticals
CTI Clinical Trial and Consulting Services

Completed

Prevention of Delayed Graft Function Using Eculizumab Therapy (PROTECT Study)

Delayed Graft Function

France, Germany, Italy, Spain, United States, Canada, Brazil, Australia, Czechia
CTI-1, LLC
GlaxoSmithKline; CTI Clinical Trial and Consulting Services

Completed

A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure (COMPARE)

Congestive Heart Failure

United States
DiscGenics, Inc.
CTI Clinical Trial and Consulting Services

Completed

Study to Evaluate the Safety and Preliminary Efficacy of IDCT, a Treatment for Symptomatic Lumbar Intervertebral Disc Degeneration

Degenerative Disc Disease

United States
Veloxis Pharmaceuticals
CTI Clinical Trial and Consulting Services

Completed

Pharmacokinetics of LCP-Tacro in Stable Kidney Transplant Patients

Renal Failure

United States
MaxCyte, Inc.
CTI Clinical Trial and Consulting Services

Terminated

Intraperitoneal MCY-M11 (Mesothelin-targeting CAR) for Treatment of Advanced Ovarian Cancer and Peritoneal Mesothelioma

Fallopian Tube Adenocarcinoma | Peritoneal Mesothelioma | Primary Peritoneal Carcinoma | Adenocarcinoma of the Ovary

United States
Veloxis Pharmaceuticals
CTI Clinical Trial and Consulting Services

Completed

Pharmacokinetics of LCP-Tacro in Stable Liver Transplant Patients

Liver Failure

United States
Bexion Pharmaceuticals, Inc.
CTI Clinical Trial and Consulting Services

Enrolling by invitation

Continued Treatment for Participants Enrolled in Studies of BXQ-350 (ETERNITI)

Neoplasms

United States
Angion Biomedica Corp
CTI Clinical Trial and Consulting Services

Active, not recruiting

Study to Assess Efficacy and Safety Relative to Standard of Care in Patients With COVID-19 Pneumonia

COVID-19 | Pneumonia

Brazil
Veloxis Pharmaceuticals
CTI Clinical Trial and Consulting Services; Aptuit

Completed

Pharmacokinetics of LCP-Tacro™ Once Daily and Prograf® Twice A Day in Adult De Novo Liver Transplant Patients

Liver Failure

United States
Veloxis Pharmaceuticals
CTI Clinical Trial and Consulting Services; Aptuit

Completed

Pharmacokinetics of LCP-Tacro(TM) Once Daily And Prograf® Twice A Day in Adult De Novo Kidney Transplant Patients

Renal Failure | Kidney Failure

United States
BTG International Inc.
CTI Clinical Trial and Consulting Services

Approved for marketing

Treatment Protocol of Voraxaze for Patients Experiencing or at Risk of Methotrexate Toxicity

Neoplasms
Angion Biomedica Corp
CTI Clinical Trial and Consulting Services; Everest Clinical Research; Clinical...

Active, not recruiting

Study to Prevent Acute Kidney Injury After Cardiac Surgery Involving Cardiopulmonary Bypass

Acute Kidney Injury

United States, Georgia, Canada, Brazil
Olatec Therapeutics LLC
CTI Clinical Trial and Consulting Services

Terminated

Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome

Covid19 | Cytokine Release Syndrome

United States, Switzerland
Bexion Pharmaceuticals, Inc.
CTI Clinical Trial and Consulting Services

Terminated

A Study of BXQ-350 in Children and Young Adults With Relapsed Solid Tumors (KOURAGE)

Neoplasms

United States
Bexion Pharmaceuticals, Inc.
CTI Clinical Trial and Consulting Services

Recruiting

BXQ-350 Pharmacokinetic/Pharmacodynamic Study in Cancer Patients (RETRO)

Chemotherapy-induced Peripheral Neuropathy | Neuropathy;Peripheral

United States
Bexion Pharmaceuticals, Inc.
CTI Clinical Trial and Consulting Services

Recruiting

A Study of BXQ-350 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) or Diffuse Midline Glioma (DMG) (KONQUER)

Diffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma, H3 K27M-Mutant

United States
Bexion Pharmaceuticals, Inc.
CTI Clinical Trial and Consulting Services

Completed

Phase 1 Study of BXQ-350 in Adult Patients With Advanced Solid Tumors

Neoplasms

United States
Angion Biomedica Corp
CTI Clinical Trial and Consulting Services

Active, not recruiting

Reduce the Severity of DGF in Recipients of a Deceased Donor Kidney

Delayed Graft Function

United States

Clinical Trials Sponsored by Clinical Trial Consultants, CTC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Switzerland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations